Evidence map›Paper›PMID 28939770›Full record

ArticleThe Journal of biological chemistry2017

Myristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice.

Sungjin Kim, Xiangkun Yang, Qianjin Li, Meng Wu, Leah Costyn, Zanna Beharry, Michael G Bartlett, Houjian Cai

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sungjin KimFrom the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602 and.
Xiangkun YangFrom the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602 and.
Qianjin LiFrom the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602 and.
Meng WuFrom the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602 and.
Leah CostynFrom the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602 and.
Zanna Beharrythe Department of Chemistry and Physics, Florida Gulf Coast University, Fort Myers, Florida 33965.
Michael G BartlettFrom the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602 and.
Houjian CaiFrom the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602 and caihj@uga.edu.
University of Georgia · USFlorida Gulf Coast University · US

Funding

Targeting myristoylation of Src family kinases for inhibition of prostate tumorigenesisR01CA172495 · NCI · UNIVERSITY OF GEORGIA · PI CAI, HOUJIAN · 2013 to 2017
$1.7M
NCI NIH HHS R01 CA172495
6 · The paper itself

Abstract

Exogenous fatty acids provide substrates for energy production and biogenesis of the cytoplasmic membrane, but they also enhance cellular signaling during cancer cell proliferation. However, it remains controversial whether dietary fatty acids are correlated with tumor progression. In this study, we demonstrate that increased Src kinase activity is associated with high-fat diet-accelerated progression of prostate tumors and that Src kinases mediate this pathological process. Moreover, in the

Indexed as

AcylationAmino Acid SubstitutionAnimalsAntineoplastic AgentsCell Line, TumorCSK Tyrosine-Protein KinaseDiet, High-FatHumansMaleMice, Inbred C57BLMice, SCIDMutationMyristic AcidNeoplasm ProteinsProstateProstatic NeoplasmsAntineoplastic AgentsCSK protein, humanCSK Tyrosine-Protein KinaseMyristic AcidNeoplasm ProteinsProtein Kinase InhibitorsProto-Oncogene Proteins pp60(c-src)src-Family Kinasesdietfatty acidprostate cancerprotein myristoylationSrc

Identifiers

PMID28939770
PMCPMC5682955
OpenAlexW2759011794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.